Literature DB >> 7037612

The Thomsen-Friedenreich (TF) receptor: an old history with new mystery.

G Uhlenbruck.   

Abstract

The Thomsen-Friedenreich (TF) receptor represents the cryptic precursor structure of the human MN blood group system. Blood group antigens, however, are no longer regarded to be restricted to red cells because most of them are carbohydrate markers. Therefore, these anti-blood group antibodies, especially blood group specific lectins, can be widely used to detect different carbohydrate units of numerous glycoconjugates in several organs. Blood group antigens of carbohydrate character and their precursors seem to be important signals during malignant transformation of normal cells, as they can be altered in different ways within the architecture of the cancer cell membrane. In this connection, the significance of the TF receptor is presented, as well as its position among other and different anti-galactose specific reagents (in the broadest sense) from various sources. The biological role of these lectins and lectin analogues is discussed and a purification method is recommended.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037612     DOI: 10.3109/08820138109093459

Source DB:  PubMed          Journal:  Immunol Commun        ISSN: 0090-0877


  20 in total

Review 1.  [Tumor lectinology--status and perspectives of clinical application].

Authors:  H J Gabius; S Gabius
Journal:  Naturwissenschaften       Date:  1990-11

2.  Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan.

Authors:  J Beuth; H L Ko; V Schirrmacher; G Uhlenbruck; G Pulverer
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

3.  Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose.

Authors:  J Beuth; H L Ko; K Oette; G Pulverer; K Roszkowski; G Uhlenbruck
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Prevention of experimental liver metastases by arabinogalactan.

Authors:  G Uhlenbruck; J Beuth; K Oette; W Roszkowski; H L Ko; G Pulverer
Journal:  Naturwissenschaften       Date:  1986-10

5.  Combined immunostimulation (Propionibacterium avidum KP 40) and anticoagulation (heparin) prevents metastatic lung and liver colonization in mice.

Authors:  J Beuth; H L Ko; G Uhlenbruck; G Pulverer
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 6.  The Glycoscience of Immunity.

Authors:  Julie Y Zhou; Douglas M Oswald; Kelsey D Oliva; Lori S C Kreisman; Brian A Cobb
Journal:  Trends Immunol       Date:  2018-05-11       Impact factor: 16.687

7.  A method for T-antigen demonstration by a polyclonal antibody and peanut lectin; elimination of cross-reaction with naturally occurring antibodies.

Authors:  T F Orntoft
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.

Authors:  H H Sedlacek; G Hagmayer; F R Seiler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  In vivo localization of radioiodinated peanut lectin in a murine TA3/Ha mammary carcinoma model.

Authors:  A Shysh; S M Eu; A A Noujaim; M R Suresh; B M Longenecker
Journal:  Eur J Nucl Med       Date:  1985

10.  Liver lectins: mediators for metastases?

Authors:  G Uhlenbruck; J Beuth; V Weidtman
Journal:  Experientia       Date:  1983-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.